BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Anticancer prodrugs
,
Aspirin
,
rs7903146
,
PPARA
,
Metabolism of xenobiotics
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NCX
Summary
General Info
Curated Studies
Most Correlated Studies
Effect of NO-sulindac treatment on hypoxic prostate cancer cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Neuronal and astrocyte NCX isoform/splice variants: How do they participate in Na+ and Ca2+ signalli…
KB-R7943 reduces 4-aminopyridine-induced epileptiform activity in adult rats after neuronal damage i…
Rise of palmitoylation: A new trick to tune NCX1 activity.
Immunosuppressive drugs, immunophilins, and functional expression of NCX isoforms.
Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validatio…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blep…
Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ